Dr. Chitlur is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3901 Beaubien St
Detroit, MI 48201Phone+1 313-745-5515Fax+1 313-745-5432
Education & Training
- Children's Hospital of MichiganFellowship, Pediatric Hematology/Oncology, 2001 - 2005
- Henry Ford Hospital/Wayne State UniversityResidency, Pediatrics, 1994 - 1997
- Kempegowda Institute of Medical ScienceClass of 1992
Certifications & Licensure
- MI State Medical License 1997 - 2025
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- America’s best physician National Consumer Advisory Board, 2019-2023
- Top Doc Hour Magazine, 2019-2022
- Super Doctor SuperDoctors.com
Clinical Trials
- Personalized Prediction of Tolerance and Immunogenicity in Hemophilia Start of enrollment: 2012 Jun 01
Publications & Presentations
PubMed
- 9 citationsThe History of Extracorporeal Membrane Oxygenation and the Development of Extracorporeal Membrane Oxygenation Anticoagulation.Robert Bartlett, Deepa J Arachichilage, Meera Chitlur, Shiu-Ki Rocky Hui, Cindy Neunert
Seminars in Thrombosis and Hemostasis. 2024-02-01 - Association of laboratory test results with the bleeding history in patients with inherited platelet function disorders (the Bleeding Assesment Tool - LABoratory tests...Paolo Gresele, Emanuela Falcinelli, Loredana Bury, Marie-Christine Alessi, Giuseppe Guglielmini
Research and Practice in Thrombosis and Haemostasis. 2024-01-01 - Balancing anticoagulation and hemostasis in an infant with severe hemophilia A during cardiac transplantation: Review of the literature and development of a surgical p...Katherine Regling, Swati Sehgal, Wendy Hollon, Patricia Rayner, Lori Stricker
Pediatric Blood & Cancer. 2024-01-01
Abstracts/Posters
- On the Role of F8 Sequence Mismatch and Class-II Human Leukocyte Antigen Binding in the Development of Neutralizing Antibodies (Inhibitors) Directed Against Therapeuti...Meera B. Chitlur, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- An Update on rFVIIa Use in Females with Rare Bleeding Disorders61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Genetics of Factor VIII Inhibitor Development in Hemophilia Patients: Novel Statistical Approaches in the PATH Study2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Efficacy of an Extended Half-Life GlycoPEGylated rFVIII (N8-GP): Pooled Analysis of ABR (Results from Two Clinical Trials)2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: